ITM and Helmholtz Munich Sign Cooperation Agreement for the Clinical Development of Radiopharmaceutical Therapy to Treat Glioblastoma Multiforme | More News

ITM and Helmholtz Munich Sign Cooperation Agreement for the Clinical Development of Radiopharmaceutical Therapy to Treat Glioblastoma Multiforme

Related Keywords

Germany ,Neuherberg ,Bayern ,Garching ,Munich ,Reinhard Zeidler ,Steffen Schuster ,Lu Endolucinbeta ,Umwelt Gmb ,Deutsches Forschungszentrum ,Nuclear Medicine ,Helmholtz Association ,Helmholtz Munich Sign Cooperation Agreement ,Clinical Development ,Radiopharmaceutical Therapy ,Treat Glioblastoma Multiforme ,Helmholtz Munich ,Germanyi January ,Technologies Munich ,Project Leader ,Targeted Radionuclide Therapy ,Umwelt Gmbh ,Business ,Strategy ,Icensing ,Collaboration ,Merger Amp Acquisition ,Meal ,Agreement ,Sales ,Financial ,Management ,